Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
The review is devoted to the recent European recommendations' view on antihypertensive medications (AHM). The role of beta-adrenoblockers (BAB) in treating arterial hypertension (AH) patients is emphasized. Existing differences in pharmacological parameters and clinical effects are discussed fo...
Autor Principal: | M. G. Bubnova |
---|---|
Formato: | Artigo |
Idioma: | Russian |
Publicado: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Acceso en liña: | https://cardiovascular.elpub.ru/jour/article/view/1641 |
Títulos similares
-
URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
por: M. P. Savenkov, et al.
Publicado: (2016-01-01) -
NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
por: Ni Putu Wirantari, et al.
Publicado: (2013-07-01) -
THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
por: A. B. Khadzegova
Publicado: (2014-09-01) -
Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
por: T. E. Morozova, et al.
Publicado: (2013-08-01) -
Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
por: V. I. Makolkin, et al.
Publicado: (1970-01-01)